Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma

  • Technology appraisal guidance
  • TA306
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence